Carregant...
Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI
Recurrence rate ranges from 12% to 40% of all cases of Clostridium difficile infection (CDI) and proposes an exceptional clinical challenge. Conventionally, treatment options of CDI have been limited to regimes of established antibiotics (eg, pulsed/tapered vancomycin) or “improvised” alternative an...
Guardat en:
| Publicat a: | Rev Esp Quimioter |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Sociedad Española de Quimioterapia
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755365/ https://ncbi.nlm.nih.gov/pubmed/31475811 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|